I agree that this site is using cookies. You can find further informations here.
X
Dimou, Argyris
15  results:
Search for persons X
?
1

Tumor Hypoxia Heterogeneity Affects Radiotherapy: Inverse-P..:

Dimou, Argyris ; Argyrakis, Panos ; Kopelman, Raoul
Entropy.  24 (2022)  1 - p. 86 , 2022
Link: https://doi.org/10.3390/..
 
?
2

Tumor Biochemical Heterogeneity and Cancer Radiochemotherap..:

Dimou, Argyris ; Argyrakis, Panos ; Kopelman, Raoul
Entropy.  24 (2022)  8 - p. 1069 , 2022
Link: https://doi.org/10.3390/..
 
?
3

A network SIRX model for the spreading of COVID-19:

Dimou, Argyris ; Maragakis, Michael ; Argyrakis, Panos
Physica A: Statistical Mechanics and its Applications.  590 (2022)  - p. 126746 , 2022
Link: https://doi.org/10.1016/..
 
?
4

Tumor Hypoxia Heterogeneity Affects Radiotherapy: Inverse-P..:

Dimou, Argyris ; Argyrakis, Panos ; Kopelman, Raoul
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774722/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
5

Tumor Biochemical Heterogeneity and Cancer Radiochemotherap..:

Dimou, Argyris ; Argyrakis, Panos ; Kopelman, Raoul
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9407148/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
6

Tumor Biochemical Heterogeneity and Cancer Radiochemotherap..:

Argyris Dimou ; Panos Argyrakis ; Raoul Kopelman
https://dx.doi.org/10.3390/e24081069.  , 2022
Link: https://doi.org/10.3390/..
 
?
7

Tumor Hypoxia Heterogeneity Affects Radiotherapy: Inverse-P..:

Argyris Dimou ; Panos Argyrakis ; Raoul Kopelman
https://dx.doi.org/10.3390/e24010086.  , 2022
Link: https://doi.org/10.3390/..
 
?
8

Tumor Biochemical Heterogeneity and Cancer Radiochemotherap..:

Argyris Dimou ; Panos Argyrakis ; Raoul Kopelman
https://www.mdpi.com/1099-4300/24/8/1069.  , 2022
Link: https://doi.org/10.3390/..
 
?
9

Tumor Hypoxia Heterogeneity Affects Radiotherapy: Inverse-P..:

Argyris Dimou ; Panos Argyrakis ; Raoul Kopelman
https://www.mdpi.com/1099-4300/24/1/86.  , 2022
Link: https://doi.org/10.3390/..
 
?
10

Positron emission tomography after response to rituximab-CH..:

Vassilakopoulos, Theodoros P. ; Papageorgiou, Sotirios G. ; Angelopoulou, Maria K....
Annals of Hematology.  , 2021
Link: https://doi.org/10.1007/..
 
?
11

Serum ferritin and ECOG performance status predict the resp..:

Papageorgiou, Sotirios G. ; Kotsianidis, Ioannis ; Bouchla, Anthi...
Therapeutic Advances in Hematology.  11 (2020)  - p. 204062072096612 , 2020
Link: https://doi.org/10.1177/..
 
?
12

Characterization of nitrogen-fixing bacteria isolated from ..:

Venieraki, Anastasia ; Dimou, Maria ; Vezyri, Eleni...
The Journal of Microbiology.  49 (2011)  4 - p. 525-534 , 2011
Link: https://doi.org/10.1007/..
 
?
13

Real-life Experience With Rituximab-CHOP Every 21 or 14 Day..:

KARAKATSANIS, STAMATIS J ; BOUZANI, MARIA ; SYMEONIDIS, ARGYRIS...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087089/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
14

Identification of Very Low‐Risk Subgroups of Patients with ..:

Vassilakopoulos, Theodoros P ; Michail, Michail ; Papageorgiou, Sotirios...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265336/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
15

Serum ferritin and ECOG performance status predict the resp..:

Sotirios G. Papageorgiou ; Ioannis Kotsianidis ; Anthi Bouchla...
https://doi.org/10.1177/2040620720966121.  , 2020
Link: https://doi.org/10.1177/..
 
1-15